Evolent Health, Inc. - Class A Shares
Evolent Health provides healthcare services including technology, analytics, and services for healthcare organizations.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Evolent Health's stock with a target price of $17.5, indicating strong growth potential.
Financial Health
Evolent Health shows decent revenue and cash flow, but lower profit margins may raise concerns.
Dividend
Evolent Health, Inc. currently offers a projected dividend of $0.43, which results in a below average yield. If you invested $1000 you would be paid $4.30 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring EVH
Following Buffett's Healthcare Bet
Warren Buffett's Berkshire Hathaway is making a major $2.1 billion bet on UnitedHealth, signaling a strategic shift toward the healthcare sector. This theme focuses on other health insurers and healthcare providers that could benefit from this renewed investor confidence.
Published: August 15, 2025
Explore BasketHealthcare's Efficiency Imperative
UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.
Published: July 30, 2025
Explore BasketHealthcare In The Crosshairs: Insurers Under Scrutiny
The Department of Justice is investigating UnitedHealth Group's Medicare billing, creating uncertainty for the nation's largest insurer. This situation presents a potential opportunity for rival health insurers to gain market share and for compliance-focused companies that help the industry navigate complex regulations.
Published: July 25, 2025
Explore BasketHealthcare Billing Integrity
This group of stocks includes companies positioned to benefit from increased focus on healthcare billing compliance. Carefully selected by professional analysts, these stocks represent both healthcare tech providers offering compliance solutions and competing insurers who may gain market share amid regulatory scrutiny.
Published: July 11, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Value‑based care tailwind
The shift to value‑based reimbursement can increase demand for Evolent's services, though adoption rates and reimbursement rules can vary and affect outcomes.
Technology plus services
A combined software and services model offers recurring revenue potential, but execution and contract performance remain critical to margin and growth.
Policy and payer dynamics
Regulatory, payer and market changes can materially influence results — investors should watch policy shifts and payer relationships carefully.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Thermo Fisher Scientific, Inc.
Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.
Intuitive Surgical, Inc.
A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties
